Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo - Concepedia

Concepedia

Publication | Open Access

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

DOI Full Paper Access

822

Citations

236

References

2015

Year

Daniel Sommermeyer, Michael Hudecek, Paula L. Kosasih, Tea Gogishvili, David G. Maloney, Cameron J. Turtle, Stanley R. Riddell

Superior Antitumor ReactivityTumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseMedicineT-regulatory CellImmunologyAntigen ProcessingAutoimmunityImmunotherapyCd4+ SubsetsCell BiologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1